Sun Pharma partners with AstraZeneca India over Type II diabetes medicine dapagliflozin
Posted on24 Mar 2016
Comments0
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name ‘Oxra’ Sun Pharma and AstraZeneca Pharma India announced... Read More
AstraZeneca’s launch of Forxiga in India
Posted on11 Jun 2015
Comments0
Brand Name: Forxiga Marketed By: Astra Zeneca Molecule: Dapagliflozin Drug Class: Gliflozin Mechanism of Action: Dapagliflozin inhibits subtype 2 of the sodium-glucose... Read More